Elsevier

Seminars in Perinatology

Volume 41, Issue 7, November 2017, Pages 392-400
Seminars in Perinatology

Maternal microbiomes in preterm birth: Recent progress and analytical pipelines

https://doi.org/10.1053/j.semperi.2017.07.010Get rights and content

Abstract

Worldwide, 10% of babies are born preterm, defined as birth before 37 weeks' gestation. We have had little success in developing strategies to prevent preterm births, the majority of which are due to infection or are idiopathic. An emerging hypothesis is that the maternal microbiome—the bacteria that inhabit the mother's body and play vital functions in normal health—contributes to the etiology of preterm birth. Here, we highlight the latest data revealing correlations between preterm birth and maternal intestinal, vaginal, cervical, and placental microbiomes. Additionally, we describe the most commonly used comparative microbiome analysis methods and highlight important issues to consider when conducting such studies.

Introduction

The World Health Organization estimates that each year, 15 million infants are born preterm, putting them at increased risk of morbidity and mortality.1 Simplistically, preterm birth (PTB) occurs when normal term labor events—uterine contractions and cervical remodeling—occur early.2 However, PTB is challenging to explain, predict, and prevent because up to 40–45% of cases are idiopathic (spontaneous), and numerous risk factors are known, including maternal history, demographics, nutritional status, stress, and infection.2

Approximately 30% of PTB cases are caused by infection and inflammation.2 Traditionally, infection-related PTB was thought to ensue from foreign microbes reaching the uterus via ascending infection or hematogenous transfer. During ascending infections, microbes from the vagina travel upward through the cervix to reach the fetal membranes. For example, the presence of Mycoplasma spp., Ureaplasma spp., and Candida spp. and Candida spp., in the vagina is associated with PTB.3 Hematogenous infection occurs when bacteria travel through the blood stream from another site in the body and then traverse the placenta at the maternal–fetal interface.2

Although foreign bacteria are important causes of PTB, current research in this area is building on the observation that, far from being sterile, the human body is home to millions of microorganisms.4 Collectively, all of the bacterial genomes present in or on our body surfaces are known as the human microbiome, and each body niche has its own resident microbes. These bacteria contribute to human health in many ways, such as providing resistance to pathologic infection, breaking down nutrients, and educating the immune system.4, 5 In addition to contributing to physiology, microbiome communities respond to physiology. Pregnancy is a period of major physiological changes,6 such as immunological shifts and the vascular remodeling and metabolic changes needed to promote exchange of nutrients, gases, and wastes with the developing fetus.7 Thus, the microbial community structure in various maternal niches has the potential to shift during pregnancy.6 Although many of these changes may benefit or cause no harm to the mother and fetus, we are beginning to learn that dysbiosis of the maternal microbiomes is associated with adverse pregnancy outcomes such as PTB.

Here, we review human microbiome studies that define the microbiomes in key maternal niches and identify associations with both term and preterm birth. Additionally, we describe common technical, analytical, and statistical approaches used to conduct maternal microbiome studies. Rigorous studies together with curated microbiome data will provide an in-depth understanding of the maternal microbiomes and their impact on pregnancy and, hopefully, identify new therapeutic strategies to decrease the incidence and burden of PTB.

Section snippets

Maternal intestinal microbiome changes during pregnancy

A healthy gastrointestinal tract, dominated by Bacteroidetes and Firmicutes, contains numerous beneficial microbes that generate vitamins, break down complex foods, and synthesize products that can keep potentially harmful microbes at bay8 (Fig.). Because the intestinal microbiome regulates critical metabolic processes, diseases, such as obesity and allergy, may arise when the community structure is abnormal.9

Koren et al.10 used stool samples to characterize the maternal gut microbiome during

Cervical and uterine microbiomes

Vaginal microbes associated with PTB most likely reach the uterus by traveling through the cervix (Fig.). Thus, more and more studies are beginning to address how microbes inhabiting this particular niche contribute to the PTB outcome. During the 2nd trimester of pregnancy, in women with a short cervix, the preponderance of specific Lactobacillus species correlates with the gestational age at delivery—increased vaginal Lactobacillus iners is associated with preterm birth and L. crispatus is

Placental microbiome

Although the placenta was long thought to be germ-free, multiple histological and high-throughput sequencing studies have suggested that the placenta harbors its own microbiome31 (Fig.). For example, our group used a variety of staining methods to demonstrate the presence of intracellular microbes in the basal plate (the maternal–fetal interface) of term and preterm placentas.32 Aagaard et al. used 16S sequencing and whole-genome shotgun sequencing to profile bacteria in term and preterm-cross

Methodology of pregnancy microbiome research

The human maternal microbiome studies using high-throughput sequencing have revealed promising associations between microbial composition and health and PTB and have provided a wealth of sequencing datasets, some of which has been made publically available. The majority of associations noted thus far between maternal microbiomes and PTB are qualitative, which is a critical first step. A second priority is to develop the most complete and concise methodology for performing high-throughput

Prospectus

The majority of associations noted thus far between microbiomes and PTB are qualitative. Long term, the goal of this field will be to identify unique bacteria or bacterial communities that can be targeted to prevent PTB. In such work, it will be important to consider the ecological dynamics of bacterial species and their interactions with the host environment. Currently, infection- and inflammation-related therapies to reduce PTB focus on either targeting the causal microbes, which requires

Acknowledgments

We thank Dr. Deborah Frank for editing. This work was supported by a Preventing Prematurity Initiative grant from the Burroughs Wellcome Fund, a Prematurity Research Initiative Investigator award 21-FY13-28 from the March of Dimes, NIH grant R01HD091218 (to IUM), and NIH grant 2T32GM007067-42 (supporting LAP).

References (73)

  • P.J. Turnbaugh et al.

    The human microbiome project

    Nature

    (2007)
  • E.A. Grice et al.

    The human microbiome: our second genome

    Annu Rev Genomics Hum Genet

    (2012)
  • M. Nuriel-Ohayon et al.

    Microbial changes during pregnancy, birth, and infancy

    Front Microbiol

    (2016)
  • P. Soma-Pillay et al.

    Physiological changes in pregnancy

    Cardiovasc J Afr

    (2016)
  • A.B. Shreiner et al.

    The gut microbiome in health and in disease

    Curr Opin Gastroenterol

    (2015)
  • S. Carding et al.

    Dysbiosis of the gut microbiota in disease

    Microb Ecol Health Dis

    (2015)
  • D.A. Chernikova et al.

    Fetal exposures and perinatal influences on the stool microbiota of premature infants

    J Matern Fetal Neonatal Med

    (2016)
  • L.F. Stinson et al.

    Planting the seed: origins, composition, and postnatal health significance of the fetal gastrointestinal microbiota

    Crit Rev Microbiol

    (2017)
  • J. Ravel et al.

    Vaginal microbiome of reproductive-age women

    Proc Natl Acad Sci U S A

    (2011)
  • J. Ravel et al.

    Translating the vaginal microbiome: gaps and challenges

    Genome Med

    (2016)
  • S.J. Klebanoff et al.

    Control of the microbial flora of the vagina by H2O2-generating lactobacilli

    J Infect Dis

    (1991)
  • A.L. Dunlop et al.

    Maternal microbiome and pregnancy outcomes that impact infant health: a review

    Adv Neonatal Care

    (2015)
  • B. Cao et al.

    Placental microbiome and its role in preterm birth

    Neoreviews

    (2014)
  • R.M. Brotman

    Vaginal microbiome and sexually transmitted infections: an epidemiologic perspective

    J Clin Invest

    (2011)
  • R. Romero et al.

    The composition and stability of the vaginal microbiota of normal pregnant women is different from that of non-pregnant women

    Microbiome

    (2014)
  • D.A. MacIntyre et al.

    The vaginal microbiome during pregnancy and the postpartum period in a European population

    Sci Rep

    (2015)
  • W. Chaim et al.

    The relationship between bacterial vaginosis and preterm birth. A review

    Arch Gynecol Obstet

    (1997)
  • S.L. Hillier et al.

    Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group

    N Engl J Med

    (1995)
  • L.M. Kindinger et al.

    The interaction between vaginal microbiota, cervical length, and vaginal progesterone treatment for preterm birth risk

    Microbiome

    (2017)
  • J. Ghartey et al.

    Women with preterm birth have a distinct cervicovaginal metabolome

    Am J Obstet Gynecol

    (2015)
  • R. Romero et al.

    The vaginal microbiota of pregnant women who subsequently have spontaneous preterm labor and delivery and those with a normal delivery at term

    Microbiome

    (2014)
  • M. Kacerovsky et al.

    Cervical microbiota in women with preterm prelabor rupture of membranes

    PloS One

    (2015)
  • H. Verstraelen et al.

    Characterisation of the human uterine microbiome in non-pregnant women through deep sequencing of the V1-2 region of the 16S rRNA gene

    PeerJ

    (2016)
  • M.S. Payne et al.

    Exploring preterm birth as a polymicrobial disease: an overview of the uterine microbiome

    Front Immunol

    (2014)
  • Y.W. Han et al.

    Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth

    Infect Immun

    (2004)
  • E. Pelzer et al.

    Review: Maternal health and the placental microbiome

    Placenta

    (2016)
  • Cited by (29)

    • Female genital tract microbiota affecting the risk of preterm birth: What do we know so far? A review

      2020, European Journal of Obstetrics and Gynecology and Reproductive Biology
      Citation Excerpt :

      A possible mechanism for inducing labour involves impeding the efficacy of autophagy. Autophagy is a protective mechanism trophoblasts utilise against infections [12]. Moreover, levels of cytokines such as TNF.

    • Is amniotic fluid of women with uncomplicated term pregnancies free of bacteria?

      2018, American Journal of Obstetrics and Gynecology
      Citation Excerpt :

      The evidence of a placental microbiota is conflicting, nonetheless we hypothesize that in pregnancies with a dysfunctional placenta, such as in infections, fetal growth restriction, or preeclampsia, prenatal microbial intraamniotic invasion is possible. This is supported by findings of an altered placental microbiome in preterm births with and without chorioamnioinitis.11,12,40–42 In a recent study by Doyle et al,12 a placental microbiome was identified in 50% of the samples (by 16S rRNA sequencing), and specific bacterial communities were found to be associated with chorioamnionitis and low birthweight.

    View all citing articles on Scopus
    View full text